136 related articles for article (PubMed ID: 2650783)
1. Anti LFA1 monoclonal antibody for the prevention of graft rejection after T cell-depleted HLA-matched bone marrow transplantation for leukemia in adults.
Maraninchi D; Mawas C; Stoppa AM; Gaspard MH; Marit G; Van Ekthoven A; Reiffers J; Olive D; Hirn M; Delaage M
Bone Marrow Transplant; 1989 Mar; 4(2):147-50. PubMed ID: 2650783
[TBL] [Abstract][Full Text] [Related]
2. XomaZyme-CD5 immunotoxin in conjunction with partial T cell depletion for prevention of graft rejection and graft-versus-host disease after bone marrow transplantation from matched unrelated donors.
Koehler M; Hurwitz CA; Krance RA; Coustan-Smith E; Williams LL; Santana V; Ribeiro RC; Brenner MK; Heslop HE
Bone Marrow Transplant; 1994 May; 13(5):571-5. PubMed ID: 7519937
[TBL] [Abstract][Full Text] [Related]
3. Transplantation of HLA-haploidentical T-cell-depleted marrow for leukemia: addition of cytosine arabinoside to the pretransplant conditioning prevents rejection.
Bozdech MJ; Sondel PM; Trigg ME; Longo W; Kohler PC; Flynn B; Billing R; Anderson SA; Hank JA; Hong R
Exp Hematol; 1985 Dec; 13(11):1201-10. PubMed ID: 3905427
[TBL] [Abstract][Full Text] [Related]
4. Prevention of graft-versus-host disease with anti-CD5 ricin A chain immunotoxin after CD3-depleted HLA-nonidentical marrow transplantation in pediatric leukemia patients.
Przepiorka D; Chan KW; Champlin RE; Culbert SJ; Petropoulos D; Ippoliti C; Khouri I; Huh YO; Vreisendorp H; Deisseroth AB
Bone Marrow Transplant; 1995 Dec; 16(6):737-41. PubMed ID: 8750262
[TBL] [Abstract][Full Text] [Related]
5. Total lymphoid irradiation to prevent graft rejection in recipients of HLA non-identical T cell-depleted allogeneic marrow.
Soiffer RJ; Mauch P; Tarbell NJ; Anderson KC; Freedman AS; Rabinowe SN; Takvorian T; Murrey CI; Coral F; Bosserman L
Bone Marrow Transplant; 1991 Jan; 7(1):23-33. PubMed ID: 2043874
[TBL] [Abstract][Full Text] [Related]
6. Failure of a CD18/anti-LFA1 monoclonal antibody infusion to prevent graft rejection in leukemic patients receiving T-depleted allogeneic bone marrow transplantation.
Baume D; Kuentz M; Pico JL; Beaujean F; Cordonnier C; Vernant JP; Hayat M; Bernard A
Transplantation; 1989 Mar; 47(3):472-4. PubMed ID: 2564220
[TBL] [Abstract][Full Text] [Related]
7. Elevated inflammatory cytokine levels in bone marrow graft rejection.
Nagler A; Or R; Nisman B; Kalickman I; Slavin S; Barak V
Transplantation; 1995 Nov; 60(9):943-8. PubMed ID: 7491698
[TBL] [Abstract][Full Text] [Related]
8. A correlation between conditioning and engraftment in recipients of MHC-mismatched T cell-depleted murine bone marrow transplants.
Soderling CC; Song CW; Blazar BR; Vallera DA
J Immunol; 1985 Aug; 135(2):941-6. PubMed ID: 3891856
[TBL] [Abstract][Full Text] [Related]
9. Preliminary characterization of functional residual host-type T lymphocytes following conditioning for allogeneic HLA-matched bone marrow transplantation (BMT).
Kedar E; Or R; Naparstek E; Zeira E; Slavin S
Bone Marrow Transplant; 1988 Mar; 3(2):129-40. PubMed ID: 3048477
[TBL] [Abstract][Full Text] [Related]
10. Control of graft-versus-host disease and graft rejection by T cell depletion of donor and recipient with Campath-1 antibodies. Results of matched sibling transplants for malignant diseases.
Hale G; Waldmann H
Bone Marrow Transplant; 1994 May; 13(5):597-611. PubMed ID: 8054913
[TBL] [Abstract][Full Text] [Related]
11. Irradiated donor buffy coat following T cell-depleted bone marrow transplants.
Gratwohl A; Tichelli A; Würsch A; Dieterle A; Lori A; Thomssen C; Baldomero H; de Witte T; Nissen C; Speck B
Bone Marrow Transplant; 1988 Nov; 3(6):577-82. PubMed ID: 3063326
[TBL] [Abstract][Full Text] [Related]
12. Graft failure after T cell-depleted bone marrow transplantation: clinical and immunological characteristics and response to immunosuppressive therapy.
Bunjes D; Wiesneth M; Hertenstein B; Schmeiser T; Arnold R; Heit W
Bone Marrow Transplant; 1990 Nov; 6(5):309-14. PubMed ID: 1705459
[TBL] [Abstract][Full Text] [Related]
13. Laboratory control in predicting clinical efficacy of T cell-depletion procedures used for prevention of graft-versus-host disease: importance of limiting dilution analysis.
Marciniak E; Romond EH; Thompson JS; Henslee PJ
Bone Marrow Transplant; 1988 Nov; 3(6):589-98. PubMed ID: 3063328
[TBL] [Abstract][Full Text] [Related]
14. Prevention of bone marrow and cardiac graft rejection in an H-2 haplotype disparate mouse combination by an anti-LFA-1 antibody.
Cavazzana-Calvo M; Sarnacki S; Haddad E; De Coene C; Calise D; Yvon E; Cerf-Bensussan N; Fischer A
Transplantation; 1995 Jun; 59(11):1576-82. PubMed ID: 7778173
[TBL] [Abstract][Full Text] [Related]
15. Depletion of T-lymphocytes in donor marrow with pan-T monoclonal antibodies and complement for prevention of acute graft-versus-host disease: a pilot study on 29 patients.
Herve P
J Natl Cancer Inst; 1986 Jun; 76(6):1311-6. PubMed ID: 3520074
[TBL] [Abstract][Full Text] [Related]
16. Unrelated donor bone marrow transplantation without T cell depletion using a chemotherapy only condition regimen. Low incidence of failed engraftment and severe acute GVHD.
Topolsky D; Crilley P; Styler MJ; Bulova S; Brodsky I; Marks DI
Bone Marrow Transplant; 1996 Apr; 17(4):549-54. PubMed ID: 8722353
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of graft failure in HLA-matched and HLA-mismatched bone marrow transplant recipients.
Bosserman LD; Murray C; Takvorian T; Anderson KC; Freedman AS; Fitzsimmons J; Coral F; Nadler LM; Schlossman SF; Ritz J
Bone Marrow Transplant; 1989 May; 4(3):239-45. PubMed ID: 2659109
[TBL] [Abstract][Full Text] [Related]
18. The influence of graft-versus-host reactivity, lymphocyte depletion, and cell dose on allogeneic bone marrow engraftment.
Glass B; Uharek L; Gaska T; Gassmann W; Löffler H; Müller-Ruchholtz W
Bone Marrow Transplant; 1993; 12 Suppl 3():S41-7. PubMed ID: 8124257
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of T cell depletion of surgically resected cadaveric marrows by monoclonal antibodies: considerations in HLA-mismatched marrow transplantation.
Gress RE; Bare C; Lucas PJ; Cassel J; Nakamura H; Moses RD; Quinones RR
Prog Clin Biol Res; 1990; 333():471-88; discussion 489. PubMed ID: 2308996
[TBL] [Abstract][Full Text] [Related]
20. Chimerism studies using in situ hybridization for the Y chromosome after T cell-depleted bone marrow transplantation.
Przepiorka D; Gonzales-Chambers R; Winkelstein A; Rosenfeld C; Shadduck RK
Bone Marrow Transplant; 1990 Apr; 5(4):253-7. PubMed ID: 2337737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
